NCT01777386

Brief Summary

Tissue expansion methods have been recommended as a means of improving the clinical results with perforator flaps but in plastic surgery literature there are few clinical trials supporting this opinion. The purposes of this clinical study are to address the ''preexpanded perforator flap concept'' by demonstrating a case series of relevant reconstructive procedures and to evaluate the perforator vessel changes that happen during the expansion periods of various perforator flap donor sites.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2009

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

January 18, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 28, 2013

Completed
Last Updated

January 29, 2013

Status Verified

January 1, 2013

Enrollment Period

3.6 years

First QC Date

January 18, 2013

Last Update Submit

January 25, 2013

Conditions

Keywords

scarcontractureperforator flappreexpanded perforator flapperforator vesselartery diameter

Outcome Measures

Primary Outcomes (1)

  • Transferred tissue dimensions

    Demonstrating the amount of transferred healthy tissue exhibits the success of the technique.

    At least five months after the operation

Secondary Outcomes (1)

  • Diameter of the perforator artery in a particular tissue level

    Measured the day before the expander implantation surgery and the day before the flap transfer surgery (second session following tissue expansion)

Study Arms (2)

preexpanded flap

ACTIVE COMPARATOR

Fourteen patients were treated with fifteen '' preexpanded perforator flap surgery '' interventions. The last six cases were evaluated in terms of perforator artery diameter before and after expansion process. The preexpanded flap donor sites' perforator artery diameters were also compared with their anatomic equivalents located in the symmetric side of the body.

Procedure: preexpanded perforator flap surgery

control side

NO INTERVENTION

In six of the 14 patients, perforator artery diameter of the nonexpanded symmetric anatomical side of the body (equivalent to the expanded site)were measured.

Interventions

preexpanded flap

Eligibility Criteria

Age6 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patients with broad scars and contracture bands
  • patients with esophagocutaneous fistula
  • patients with ambiguous genitalia

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CicatrixContracture

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsJoint DiseasesMusculoskeletal DiseasesMuscular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

January 18, 2013

First Posted

January 28, 2013

Study Start

June 1, 2009

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

January 29, 2013

Record last verified: 2013-01